Thymosin alpha 1 in the prevention of infected pancreatic necrosis following acute necrotising pancreatitis (TRACE trial): protocol of a multicentre, randomised, double-blind, placebo-controlled, parallel-group trial
Introduction Infected pancreatic necrosis (IPN) and its related septic complications are the major causes of death in patients with acute necrotising pancreatitis (ANP). Therefore, the prevention of IPN is of great clinical value, and immunomodulatory therapy with thymosin alpha 1 may be beneficial....
        Saved in:
      
    
          | Main Authors: | , , , , , , , , , , , , , , , , , , , , , | 
|---|---|
| Format: | Article | 
| Language: | English | 
| Published: | 
            BMJ Publishing Group
    
        2020-09-01
     | 
| Series: | BMJ Open | 
| Online Access: | https://bmjopen.bmj.com/content/10/9/e037231.full | 
| Tags: | 
       Add Tag    
     
      No Tags, Be the first to tag this record!
   
 | 
Be the first to leave a comment!